BioCentury
ARTICLE | Clinical News

Testosterone tablet: Phase II data; Phase III

February 5, 2001 8:00 AM UTC

In a Phase II study in the U.K., COB said that its testosterone tablet maintained normal serum testosterone levels of 3-10.5 ng/ml. The compound is in Phase III testing in Europe, and COB began a 3-mo...